Evidence map›Paper›PMID 28774589›Full record

ArticleThe Journal of investigative dermatology2017

Biallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia.

Takuya Takeichi, Antonio Torrelo, John Y W Lee, Yusuke Ohno, María Luisa Lozano, Akio Kihara, Lu Liu, Yuka Yasuda, Junko Ishikawa, Takatoshi Murase and 16 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Review
  3. Human genetic defects of sphingolipid synthesis.Journal of inherited metabolic disease · 2025
    Review
  4. Article
  5. Article
  6. Associations between forensic loci and expression levels of neighboring genes may compromise medical privacy.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Ceramides in Skin Health and Disease: An Update.American journal of clinical dermatology · 2021
    Review
  12. Review
  13. Article
  14. Inherited Platelet Disorders: An Updated Overview.International journal of molecular sciences · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 16 institutions in 3 countries.

Takuya TakeichiSt. John's Institute of Dermatology, King's College London (Guy's Campus), London, UK; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Antonio TorreloDepartment of Dermatology, Hospital Infantil del Niño Jesús, Madrid, Spain.
John Y W LeeSt. John's Institute of Dermatology, King's College London (Guy's Campus), London, UK.
Yusuke OhnoFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
María Luisa LozanoCentro Regional de Hemodonación, Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
Akio KiharaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Lu LiuViapath, St. Thomas' Hospital, London, UK.
Yuka YasudaAnalytical Science Research Laboratories, Kao Corporation, Haga, Tochigi, Japan.
Junko IshikawaBiological Science Research Laboratories, Kao Corporation, Haga, Tochigi, Japan.
Takatoshi MuraseBiological Science Research Laboratories, Kao Corporation, Haga, Tochigi, Japan.
Ana Belén RodrigoDepartment of Dermatology, Hospital Sierra de Segura, Puente de Génave, Jaén, Spain.
Pablo Fernández-CrehuetDepartment of Dermatology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Yoichiro ToiDepartment of Dermatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Jemima MellerioSt. John's Institute of Dermatology, King's College London (Guy's Campus), London, UK; Department of Dermatology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
José RiveraCentro Regional de Hemodonación, Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
Vicente VicenteCentro Regional de Hemodonación, Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
David P KelsellCentre for Cell Biology and Cutaneous Research, Blizard Institute, Barts, London, UK; London School of Medicine and Dentistry, Queen Mary University of London, Whitechapel, London, UK.
Yutaka NishimuraDepartment of General Perinatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Yusuke OkunoCenter for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Daiei KojimaDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yasushi OgawaDepartment of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kazumitsu SugiuraDepartment of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan.
Michael A SimpsonDepartment of Medical and Molecular Genetics, King's College London, School of Medicine, Guy's Hospital, London, UK.
W H Irwin McLeanCentre for Dermatology and Genetic Medicine, Division of Molecular Medicine, University of Dundee, Dundee, UK.
Masashi AkiyamaDepartment of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
John A McGrathSt. John's Institute of Dermatology, King's College London (Guy's Campus), London, UK; Centre for Dermatology and Genetic Medicine, Division of Molecular Medicine, University of Dundee, Dundee, UK. Electronic address: john.mcgrath@kcl.ac.uk.
Nagoya University · JPKao Corporation (Japan) · JPCentre for Biomedical Network Research on Rare Diseases · ESHiroshima City Asa Citizens Hospital · JPHokkaido University · JPKing's College London · GBUniversity of Dundee · GBFujita Health University · JPGreat Ormond Street Hospital for Children NHS Foundation Trust · GBGuy's Hospital · GBHospital Infantil Universitario Niño Jesús · ESHospital Sierrallana · ESHospital Universitario Reina Sofía · ESInstituto de Salud Carlos III · ESQueen Mary University of London · GBSt Thomas' Hospital · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Mutations in ceramide biosynthesis pathways have been implicated in a few Mendelian disorders of keratinization, although ceramides are known to have key roles in several biological processes in skin and other tissues. Using whole-exome sequencing in four probands with undiagnosed skin hyperkeratosis/ichthyosis, we identified compound heterozygosity for mutations in KDSR, encoding an enzyme in the de novo synthesis pathway of ceramides. Two individuals had hyperkeratosis confined to palms, soles, and anogenital skin, whereas the other two had more severe, generalized harlequin ichthyosis-like skin. Thrombocytopenia was present in all patients. The mutations in KDSR were associated with reduced ceramide levels in skin and impaired platelet function. KDSR enzymatic activity was variably reduced in all patients, resulting in defective acylceramide synthesis. Mutations in KDSR have recently been reported in inherited recessive forms of progressive symmetric erythrokeratoderma, but our study shows that biallelic mutations in KDSR are implicated in an extended spectrum of disorders of keratinization in which thrombocytopenia is also part of the phenotype. Mutations in KDSR cause defective ceramide biosynthesis, underscoring the importance of ceramide and sphingosine synthesis pathways in skin and platelet biology.

Indexed as

Genetic Predisposition to DiseaseAdolescentAlcohol OxidoreductasesAllelesBiopsy, NeedleCeramidesChildHumansImmunohistochemistryIn Vitro TechniquesKeratoderma, PalmoplantarMaleMutationPedigreePrognosisSampling Studies3-ketodihydrosphingosine reductaseAlcohol OxidoreductasesCeramides

Identifiers

PMID28774589
PMCPMC5646945
OpenAlexW2736175702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.